Qube Research & Technologies LTD Amryt Pharma PLC Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$7.0 - $14.77 $2.27 Million - $4.79 Million
324,303 New
324,303 $4.73 Million
Q4 2021

Feb 01, 2022
SELL
$9.44 - $12.24 $229,543 - $297,627
-24,316 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$9.63 - $12.47 $234,163 - $303,220
24,316 New
24,316 $294,000

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email